Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial

Detalles Bibliográficos
Autores principales: Dabbous, Hany M., El‑Sayed, Manal H., El Assal, Gihan, Elghazaly, Hesham, Ebeid, Fatma F. S., Sherief, Ahmed F., Elgaafary, Maha, Fawzy, Ehab, Hassany, Sahar M., Riad, Ahmed R., TagelDin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Retraction Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462367/
https://www.ncbi.nlm.nih.gov/pubmed/34537808
http://dx.doi.org/10.1038/s41598-021-98683-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462367/
https://www.ncbi.nlm.nih.gov/pubmed/34537808
http://dx.doi.org/10.1038/s41598-021-98683-5

Ejemplares similares